Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BACKGROUND: Multicystic peritoneal mesothelioma (MCPM) is a rare neoplasm, generally considered a borderline malignancy, best treated by cytoreductive surgery (CRS) to remove macroscopic disease, combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Owing to its rarity, little has been pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahid, A, Clarke, L, Carr, N, Chandrakumaran, K, Tzivanakis, A, Dayal, S, Mohamed, F, Cecil, T, Moran, B J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944491/
https://www.ncbi.nlm.nih.gov/pubmed/33688945
http://dx.doi.org/10.1093/bjsopen/zraa001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944491/
https://www.ncbi.nlm.nih.gov/pubmed/33688945
http://dx.doi.org/10.1093/bjsopen/zraa001

Ejemplares similares